Amgen (AMGN) Q3 2024 Earnings Call Transcript

By Yahoo! Finance | Oct 30, 2024 at 08:21 PM EST

The Amgen Q3 2024 Earnings Call discussed the company's performance, pipeline updates, and growth strategies across core therapeutic areas. Highlights included strong revenue growth, progress in rare diseases, and advancements in pipeline medicines like MariTide and TEZSPIRE.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.